Recent publications on AD patients with amyloid aggregates have shown reduced expression of tRNA-modifying enzymes, including Elongator acetyltransferase complex subunit 3 (ELP3) and NOP2/Sun RNA methyltransferase 2 (NSUN2), in the hippocampus [80,87]. This evidence concerns the gene NSUN2 and Alzheimer disease.